Publications

Prospective Subgroup Analyses of the Randomized Mcl-002 (Sprint) Study: Lenalidomide Versus Investigator's Choice in Relapsed or Refractory Mantle Cell Lymphoma

AuthID
P-00N-GM2

Author(s)

Arcaini, L

Lamy, T

Walewski, J

Belada, D

Mayer, J

Radford, J

Jurczak, W

Morschhauser, F

Alexeeva, J

Rule, S

Cabecadas, J

Campo, E

Pileri, SA

Biyukov, T

Patturajan, M

Casadebaig Bravo, ML

Trneny, M

Group Author(s)

SPRINT Trial Investigators

Document Type

Article

Year published

2018

Published

in BRITISH JOURNAL OF HAEMATOLOGY, ISSN: 0007-1048

Volume: 180, Issue: 2, Pages: 224-235 (12)

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1111/bjh.15025

Wos: WOS:000419882400009

Source Identifiers

ISSN: 0007-1048

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Prospective Subgroup Analyses of the Randomized Mcl-002 (Sprint) Study: Lenalidomide Versus Investigator's Choice in Relapsed or Refractory Mantle Cell Lymphoma

Useful Links

Get Help

Federated Authentication (Click on the image)

Prospective Subgroup Analyses of the Randomized Mcl-002 (Sprint) Study: Lenalidomide Versus Investigator's Choice in Relapsed or Refractory Mantle Cell Lymphoma

Useful Links

Get Help